KalVista Provides Business Update; Phase 2 Clinical Trial in HAE Expected to Complete Enrollment in 2019 with Data in 2020; Phase 2 Clinical Trial Data in DME Expected This Quarter November 14, 2019
Bicycle Announces First Patient Dosed in Phase I/II Trial for Patients with Advanced Solid Tumors November 13, 2019
Bicycle Therapeutics Reports Third Quarter 2019 Financial Results and Corporate Update November 8, 2019
FDA Grants Fast Track Designation for the Development of Mitobridge’s ASP1128 for Patients at Risk for Acute Kidney Injury November 4, 2019
PTC Therapeutics Announces Results from Gene Therapy Treatment Demonstrating Sustained Improvements October 25, 2019
